Product Information

BUPROPION HCL SR 200 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.1060 per EA under NDC 43547029010. Its NADAC has been published 546 times since Jun 8, 2016.

FDA first approved this application on May 26, 2015. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPROPION HCL SR 200 MG TABLET

bupropion hydrochloride
$0.1060per EA

Strength

200 mg/1

NDC

43547029010

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202304

FDA Approved

5/26/2015

TE Code

AB1

On Market Since

11/1/2014

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL SR 200 MG TABLET has been published 546 times since Jun 8, 2016, and over the history we have for it it has declined 68.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1060 per EA
All-time high$0.3490 (Oct 12, 2016)
All-time low$0.1002 (Nov 19, 2025)
52-week high$0.1150
52-week low$0.1002
Median price$0.1823
Average price$0.1958
Largest weekly change+39.8% (May 19, 2021)
Weeks tracked546
Tracking sinceJun 8, 2016

Price History

1W

+2.3%

1M

+2.3%

3M

-2.5%

6M

-2.2%

1Y

+5.9%

3Y

-32.9%

5Y

-41.8%

All

-68.5%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUPROPION HCL SR 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 200 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.1060 per EA (NDC 43547029010), effective Nov 18, 2026.

How has the price of BUPROPION HCL SR 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL SR 200 MG TABLET has declined 68.5%. It has been tracked across 546 weekly CMS publications since Jun 8, 2016.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 200 MG TABLET?

Since Jun 8, 2016, the NADAC for BUPROPION HCL SR 200 MG TABLET has ranged from a low of $0.1002 (Nov 19, 2025) to a high of $0.3490 (Oct 12, 2016), with a median of $0.1823 per EA.

Are there cheaper alternatives to BUPROPION HCL SR 200 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL SR 200 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPROPION HCL SR 200 MG TABLET?

BUPROPION HCL SR 200 MG TABLET (NDC 43547029010) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.